Details of Epigenetic Molecule(EM)
General Information of EM (ID: EM00029) | |||||||
---|---|---|---|---|---|---|---|
Official Symbol |
HIST1H3A
|
||||||
Official Full Name |
histone cluster 1, H3a
|
||||||
Synonym |
H3.1;H3.f;H3/A;H3/b;H3/c;H3/d;H3/f;H3/h;H3/i;H3/j;H3/k;H3/l;H3F1K;H3FA;H3FB;H3FC;H3FD;H3FF;H3FH;H3FI;H3FJ;H3FK;H3FL
|
||||||
Molecule Type |
Protein coding
|
||||||
Position On Chromosome |
chr6(Start:26020718 - End:26021186)
|
||||||
Strand |
+
|
||||||
Uniprot Entry | |||||||
ENSG ID | |||||||
Dnmivd Disease | |||||||
Disease Relevance (Click to Show/Hide) | |||||||
2C60: Carcinoma of breast | Breast cancer [Carcinoma of breast] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
6A20: Schizophrenia | Schizophrenia [Schizophrenia] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
6E8Z: Mental, behavioural or neurodevelopmental disorders | Psychiatric disorders [Mental, behavioural or neurodevelopmental disorders] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A20: Alzheimer disease | Alzheimer's disease [Alzheimer disease] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
LA02: Spina bifida | Neural tube defects [Spina bifida] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
XH9HQ1: Gastrointestinal stromal tumour | Gastrointestinal stromal tumors [Gastrointestinal stromal tumour] | ||||||
Detailed Information |
Disease Link
![]() |
Metabolite(s) with this epigenetic modification | |||||||
---|---|---|---|---|---|---|---|
Metabolite Name: Hydrogen sulfide (H2S) | |||||||
Detailed Information |
Meta Info
![]() |
[1] | |||||
Description |
H2S could induce H3K4me2 modification at specific promoters.
|
||||||
Metabolite Name: Iso-butyrate | |||||||
Detailed Information |
Meta Info
![]() |
[2], [3] | |||||
Description |
isobutyrate couldincreased lysine isobutyrylation levels on histones H3 at lysine 14.
|
||||||
Metabolite Name: Hydrogen peroxide (H2O2) | |||||||
Detailed Information |
Meta Info
![]() |
[4] | |||||
Description |
Hydrogen peroxide (H2O2) has been shown to trigger host signaling that culminates in H3S10 dephosphorylation.
|
||||||
Metabolite Name: Hydrogen peroxide (H2O2) | |||||||
Detailed Information |
Meta Info
![]() |
[4], [5] | |||||
Description |
Hydrogen peroxide (H2O2) has been shown to increase histone methylation of histone H3K27 in BEAS-2B cells.
|
||||||
Metabolite Name: Hydrogen peroxide (H2O2) | |||||||
Detailed Information |
Meta Info
![]() |
[4], [5] | |||||
Description |
Hydrogen peroxide (H2O2) has been shown to increase histone methylation of histone H3K4 in BEAS-2B cells.
|
||||||
Metabolite Name: Hydrogen peroxide (H2O2) | |||||||
Detailed Information |
Meta Info
![]() |
[4], [5] | |||||
Description |
Hydrogen peroxide (H2O2) has been shown to decrease Histone Acetylation of histone H3K8 in BEAS-2B cells.
|
||||||
Metabolite Name: Hydrogen peroxide (H2O2) | |||||||
Detailed Information |
Meta Info
![]() |
[4], [5] | |||||
Description |
Hydrogen peroxide (H2O2) has been shown to increase histone methylation of histone H3K9 in BEAS-2B cells.
|
||||||
Metabolite Name: Ethionine | |||||||
Detailed Information |
Meta Info
![]() |
[6], [3] | |||||
Description |
Ethionine has been shown to decrease thelevels of H3K9me3 for Nang.
|
||||||
Metabolite Name: Ethionine | |||||||
Detailed Information |
Meta Info
![]() |
[6], [3] | |||||
Description |
Ethionine has been shown to decrease thelevels of H3K9me3 for Tead4.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[6], [7] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H3K4ac at the promoter of P300.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[6], [8] | |||||
Description |
Acetate has been shown to increase acetylation on histone H3 at Lysine 9.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[6], [9] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K27me3at the promoter of ER-alpha.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[6], [9] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H3K4acat the promoter of ER-alpha.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[6], [9] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K9me3at the promoter of ER-alpha.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[6], [9] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K27me3at the promoter of ER-BETA.
|
||||||
Metabolite Name: Lipopolysaccharide | |||||||
Detailed Information |
Meta Info
![]() |
[6], [10] | |||||
Description |
Lipopolysaccharide has been shown to induce histone H3 acetylation.
|
||||||
Metabolite Name: Ethionine | |||||||
Detailed Information |
Meta Info
![]() |
[6], [11] | |||||
Description |
Ethionine could reduce the histone 3-methylation at the Lysines 36.
|
||||||
Metabolite Name: Spermine | |||||||
Detailed Information |
Meta Info
![]() |
[6], [12] | |||||
Description |
Spermine could increase the expression levels of Ac-Histone H3 in HT1080 cells.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[13], [14] | |||||
Description |
Acetate could markedly enhanced H3K9 acetylation level at the promoter of LDHA.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[13], [15] | |||||
Description |
Acetate could markedly enhanced H3K56 acetylation level at the promoter of ACACA.
|
||||||
Metabolite Name: Ethionine | |||||||
Detailed Information |
Meta Info
![]() |
[16], [17] | |||||
Description |
Ethionine could reduce the histone 3-methylation at the Lysines 9.
|
||||||
Metabolite Name: Folate (B9) | |||||||
Detailed Information |
Meta Info
![]() |
[16], [17] | |||||
Description |
Folate (B9) has been shown to decrease H3K27 methylation marks in the Hes1 gene promoters.
|
||||||
Metabolite Name: Propionate | |||||||
Detailed Information |
Meta Info
![]() |
[3] | |||||
Description |
Propionate has been shown to result in the increase in histone H3 acetylation
|
||||||
Metabolite Name: Sperimidine | |||||||
Detailed Information |
Meta Info
![]() |
[3] | |||||
Description |
Spermidine has been shown to reduce the acetylation levels of Lys 18 at histone H3 in human PBMC cells.
|
||||||
Metabolite Name: Benzoate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Benzoate has been shown to enhance the H3K18 benzoylation levels in HepG2 cells.
|
||||||
Metabolite Name: Benzoate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Benzoate has been shown to enhance the H3K9 benzoylation levels in HepG2 cells.
|
||||||
Metabolite Name: Benzoate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Benzoate has been shown to enhance the H3K23 benzoylation levels in HepG2 cells.
|
||||||
Metabolite Name: Benzoate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Benzoate has been shown to enhance the H3K14 benzoylation levels in HepG2 cells.
|
||||||
Metabolite Name: Benzoate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Benzoate has been shown to enhance the H3K4 benzoylation levels in HepG2 cells.
|
||||||
Metabolite Name: Biotin (B7) | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Biotinylation is an epigenetic process in which gene expression is repressed by covalent attachment of biotin on histone H3 at K18
|
||||||
Metabolite Name: Biotin (B7) | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Biotinylation is an epigenetic process in which gene expression is repressed by covalent attachment of biotin on histone H3 at K4
|
||||||
Metabolite Name: Biotin (B7) | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Biotinylation is an epigenetic process in which gene expression is repressed by covalent attachment of biotin on histone H3 at K9
|
||||||
Metabolite Name: Folate (B9) | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Folate (B9) has been shown to decrease H3K27 methylation marks in the Neurog2 gene promoters.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at AGRP loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at ARNT2 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at ASCL1 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at AVP loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at BMP7 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at CARTPT loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at CCK loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at CORT loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at CRH loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at GALP loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at GAST loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at GHRH loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at GNRH2 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at HCRT loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at HMX2 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at KISS1 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at LHX1 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at NKX2-1 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at NPVF loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at NPW loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at NPY loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at NR5A1 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at OTP loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at OXT loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at PDYN loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at PENK loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at PNOC loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at POMC loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at POU3F2 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at PRLH loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at RAX loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at SHH loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at SIM1 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at SIX3 loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at SST loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at TRH loci.
|
||||||
Metabolite Name: Kynurenine | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Kynurenine has been shown to increase H3K4me3 at VAX1 loci.
|
||||||
Metabolite Name: Niacin (B3) | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Niacin (B3) could decrease H3K27 trimethylationat the FXN gene in friedreich's ataxia.
|
||||||
Metabolite Name: Niacin (B3) | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Niacin (B3) could decrease H3K9 trimethylationat the FXN gene in friedreich's ataxia.
|
||||||
Metabolite Name: Niacin (B3) | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Niacin (B3) could increase histone H3 acetylation at the FXN gene in friedreich's ataxia.
|
||||||
Metabolite Name: Phenylbutyrate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
Phenylbutyrate has been shown to induce increased histones H3 acetylation in D283-MED cells.
|
||||||
Metabolite Name: Riboflavin (B2) | |||||||
Detailed Information |
Meta Info
![]() |
[3], [18] | |||||
Description |
RIboflavin (B2) has been shown to activate Lysine-specific demethylase 1 (LSD1) so that decrease the accumulation of H3K4me1.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [19] | |||||
Description |
Acetate could markedly enhanced H3K9 acetylation level at the promoter of ACACA.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [19] | |||||
Description |
Acetate could markedly enhanced H3K27 acetylation level at the promoter of FASN.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [19] | |||||
Description |
Acetate could markedly enhanced H3K56 acetylation level at the promoter of FASN.
|
||||||
Metabolite Name: Butyrate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [19] | |||||
Description |
Butyrate has been shown to increase histone H3 acetylation at Foxo3A promoter.
|
||||||
Metabolite Name: Phenylbutyrate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [19] | |||||
Description |
Phenylbutyrate has been shown to induce increased histones H3 acetylation in DAOY cells.
|
||||||
Metabolite Name: Propionate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [19] | |||||
Description |
Propionate has been shown to increase histone propionylation of histone 3 lysine 23 (H3K23) in Primary myocytes.
|
||||||
Metabolite Name: Propionate | |||||||
Detailed Information |
Meta Info
![]() |
[3], [19] | |||||
Description |
Propionate has been shown to increase histone propionylation of histone 3 lysine 23 (H3K23) in C2C12 cells.
|
||||||
Metabolite Name: Hydrogen sulfide (H2S) | |||||||
Detailed Information |
Meta Info
![]() |
[20], [21] | |||||
Description |
Hydrogen sulfide (H2S) has been shown to increase H3K27 methylation at the IL-6 promoter.
|
||||||
Metabolite Name: Hydrogen sulfide (H2S) | |||||||
Detailed Information |
Meta Info
![]() |
[20], [21] | |||||
Description |
Hydrogen sulfide (H2S) has been shown to increase the methylation at lysine 9 of histone H3 at the IL-6 promoter.
|
||||||
Metabolite Name: Hydrogen sulfide (H2S) | |||||||
Detailed Information |
Meta Info
![]() |
[20], [21] | |||||
Description |
Hydrogen sulfide (H2S) has been shown to reduce the chromatin openness by decreasing histone H3 acetylation at the TNF-Alpha promoter.
|
||||||
Metabolite Name: Hydrogen sulfide (H2S) | |||||||
Detailed Information |
Meta Info
![]() |
[20], [21] | |||||
Description |
Hydrogen sulfide (H2S) has been shown to increase H3K27 methylation at TNF-Alpha promoters.
|
||||||
Metabolite Name: Hydrogen sulfide (H2S) | |||||||
Detailed Information |
Meta Info
![]() |
[20], [21] | |||||
Description |
Hydrogen sulfide (H2S) has been shown to increase the methylation at lysine 9 of histone H3 at the TNF-Alpha promoter.
|
||||||
Metabolite Name: K3 | |||||||
Detailed Information |
Meta Info
![]() |
[22], [23] | |||||
Description |
Vitamin K3 has been shown to associated with keratin 8 phosphorylation and histone H3 arylation at Cys110.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[9], [24] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K27me3at the promoter of P300.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[9], [25] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H3K4acat the promoter of ER-BETA.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[9], [25] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K9me3at the promoter of ER-BETA.
|
||||||
Metabolite Name: Flagellin | |||||||
Detailed Information |
Meta Info
![]() |
[26] | |||||
Description |
Legionella pneumophila time-dependently induced acetylation of Ac-Lys14-H3 at the IL-8 promoter depended on flagellin.
|
||||||
Metabolite Name: Flagellin | |||||||
Detailed Information |
Meta Info
![]() |
[26] | |||||
Description |
Legionella pneumophila-induced phosphorylation of P-Ser10-H3 at the IL-8 promoter depended on flagellin.
|
||||||
Metabolite Name: a-Ketoglutarate(a-Kg) | |||||||
Detailed Information |
Meta Info
![]() |
[15], [27] | |||||
Description |
a-ketoglutarate (a-KG) could decrease H3K9me3 abundance in the promoter regions of Bmp2 in aged mesenchymal stromal/stem cells.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[15], [28] | |||||
Description |
Acetate could markedly enhanced H3K9 acetylation level at the promoter of FASN.
|
||||||
Metabolite Name: Choline | |||||||
Detailed Information |
Meta Info
![]() |
[15], [28] | |||||
Description |
Choline could increase the trimethylation of H3K27 in Liver.
|
||||||
Metabolite Name: Choline | |||||||
Detailed Information |
Meta Info
![]() |
[15], [28] | |||||
Description |
Choline could increase the trimethylation of H3K27 in Cortex.
|
||||||
Metabolite Name: Choline | |||||||
Detailed Information |
Meta Info
![]() |
[15], [28] | |||||
Description |
Choline could decrease the dimethylation of H3K4 in Liver.
|
||||||
Metabolite Name: Choline | |||||||
Detailed Information |
Meta Info
![]() |
[15], [28] | |||||
Description |
Choline could increase the dimethylation of H3K9 in Liver.
|
||||||
Metabolite Name: Choline | |||||||
Detailed Information |
Meta Info
![]() |
[15], [28] | |||||
Description |
Choline could increase the dimethylation of H3K9 in Cortex.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [30] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K27me3 at the promoter of P300.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [30] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H3K4ac at the promoter of P300.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K27me3at the promoter of BRCA1.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K27me3 at the promoter of BRCA1.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H3K4acat the promoter of BRCA1.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H3K4ac at the promoter of BRCA1.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K9me3at the promoter of BRCA1.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K9me3 at the promoter of BRCA1.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K27me3 at the promoter of ER-alpha.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H3K4ac at the promoter of ER-alpha.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K9me3 at the promoter of ER-alpha.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K27me3 at the promoter of ER-BETA.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H3K4ac at the promoter of ER-BETA.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K9me3 at the promoter of ER-BETA.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K27me3at the promoter of EZH2.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K27me3 at the promoter of EZH2.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H3K4acat the promoter of EZH2.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H3K4ac at the promoter of EZH2.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K9me3at the promoter of EZH2.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K9me3 at the promoter of EZH2.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K9me3at the promoter of P300.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K9me3 at the promoter of P300.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K27me3at the promoter of SRC3.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K27me3 at the promoter of SRC3.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to increaserepressive histone marks such as H3K4acat the promoter of SRC3.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to increase repressive histone marks such as H3K4ac at the promoter of SRC3.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reducerepressive histone marks such as H3K9me3at the promoter of SRC3.
|
||||||
Metabolite Name: equol | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Equol has been shown to reduce repressive histone marks such as H3K9me3 at the promoter of SRC3.
|
||||||
Metabolite Name: Lipopolysaccharide | |||||||
Detailed Information |
Meta Info
![]() |
[29], [31] | |||||
Description |
Lipopolysaccharide (LPS) could induce transient acetylation of histone H3 lysine 9 in oral epithelial cells through the pattern recognition receptor pathway.
|
||||||
Metabolite Name: urolithin A | |||||||
Detailed Information |
Meta Info
![]() |
[32], [33] | |||||
Description |
urolithin A could enhance acetylations of Lys-9 residues of histone H3 within chromatin surrounding the promoter region of gp91-phox gene.
|
||||||
Metabolite Name: Docosahexaenoic acid | |||||||
Detailed Information |
Meta Info
![]() |
[32], [34] | |||||
Description |
docosahexaenoic acid (DHA) could reduced H3K27me3 levels.
|
||||||
Metabolite Name: eicosapentaenoic acid (EPA) | |||||||
Detailed Information |
Meta Info
![]() |
[32], [34] | |||||
Description |
eicosapentaenoic acid (EPA) could reduced H3K27me3 levels.
|
||||||
Metabolite Name: S-Adenosyl Methionine (SAM) | |||||||
Detailed Information |
Meta Info
![]() |
[35], [36] | |||||
Description |
S-Adenosyl Methionine (SAM) is the main methyl-donating substrate for DNMTs and HNMTs
|
||||||
Metabolite Name: 2-Aminoacetophenone | |||||||
Detailed Information |
Meta Info
![]() |
[37] | |||||
Description |
2-Aminoacetophenone could reduce H3K18ac at TNF-alpha promoter.
|
||||||
Metabolite Name: Hydrogen sulfide (H2S) | |||||||
Detailed Information |
Meta Info
![]() |
[38], [15] | |||||
Description |
Hydrogen sulfide (H2S) has been shown to reduce the chromatin openness by decreasing histone H3 acetylation at the IL-6 promoter.
|
||||||
Metabolite Name: Inositol phosphate | |||||||
Detailed Information |
Meta Info
![]() |
[39], [40] | |||||
Description |
Inositol phosphate could be decreased H3K9Ac in the intestinal epithelial cells.
|
||||||
Metabolite Name: a-Ketoglutarate(a-Kg) | |||||||
Detailed Information |
Meta Info
![]() |
[39], [15] | |||||
Description |
a-ketoglutarate (a-KG) could decrease H3K27me3 abundance in the promoter regions of Bmp2 in aged mesenchymal stromal/stem cells.
|
||||||
Metabolite Name: a-Ketoglutarate(a-Kg) | |||||||
Detailed Information |
Meta Info
![]() |
[39], [15] | |||||
Description |
a-ketoglutarate (a-KG) could decrease H3K27me3 abundance in the promoter regions of Nanog in aged mesenchymal stromal/stem cells.
|
||||||
Metabolite Name: a-Ketoglutarate(a-Kg) | |||||||
Detailed Information |
Meta Info
![]() |
[39], [15] | |||||
Description |
a-ketoglutarate (a-KG) could decrease H3K9me3 abundance in the promoter regions of Nanog in aged mesenchymal stromal/stem cells.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[39], [15] | |||||
Description |
Acetate could upregulate theacetylation levels of H3K56 at LDHA promoter under hypoxia.
|
||||||
Metabolite Name: Iso-butyrate | |||||||
Detailed Information |
Meta Info
![]() |
[41], [42] | |||||
Description |
isobutyrate couldincreased lysine isobutyrylation levels on histones H3 at lysine 23.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[41], [43] | |||||
Description |
Acetate could markedly enhanced H3K27 acetylation level at the promoter of LDHA.
|
||||||
Metabolite Name: a-Ketoglutarate(a-Kg) | |||||||
Detailed Information |
Meta Info
![]() |
[41], [15] | |||||
Description |
a-ketoglutarate (a-KG) could decrease H3K9me3 abundance in the promoter regions of Bmp2 in aged mesenchymal stromal/stem cells.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[41], [15] | |||||
Description |
Acetate could markedly enhanced H3K27 acetylation level at the promoter of ACACA.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[41], [15] | |||||
Description |
Acetate could upregulate theacetylation levels of H3K27 at VEGF promoter under hypoxia.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[41], [15] | |||||
Description |
Acetate could upregulate theacetylation levels of H3K56 at VEGF promoter under hypoxia.
|
||||||
Metabolite Name: Acetate | |||||||
Detailed Information |
Meta Info
![]() |
[41], [15] | |||||
Description |
Acetate could upregulate theacetylation levels of H3K9 at VEGF promoter under hypoxia.
|
||||||
Metabolite Name: Butyrate | |||||||
Detailed Information |
Meta Info
![]() |
[44], [45] | |||||
Description |
Butyrate has been shown to increase the abundances of acetylated H3K9ac.
|
||||||
Metabolite Name: Taurocholate | |||||||
Detailed Information |
Meta Info
![]() |
[44], [42] | |||||
Description |
Taurocholate could increase the levels of citrullinated histone 3 in the pancreas.
|
||||||
Metabolite Name: Iso-Valerate | |||||||
Detailed Information |
Meta Info
![]() |
[44], [46] | |||||
Description |
Isovalerate has been shown to increased bulk histone H3 acylation.
|
||||||
Metabolite Name: Sperimidine | |||||||
Detailed Information |
Meta Info
![]() |
[44], [8] | |||||
Description |
Spermidine has been shown to reduce the acetylation levels of Lys 14 at histone H3 in human PBMC cells.
|
||||||
Metabolite Name: a-Ketoglutarate(a-Kg) | |||||||
Detailed Information |
Meta Info
![]() |
[44], [15] | |||||
Description |
a-ketoglutarate (a-KG) could decrease H3K27me3 abundance in the promoter regions of Bmp4 in aged mesenchymal stromal/stem cells.
|
||||||
Metabolite Name: Butyrate | |||||||
Detailed Information |
Meta Info
![]() |
[44], [15] | |||||
Description |
Butyrate has been shown to increase the abundances of acetylated H3K9ac.
|
||||||
Metabolite Name: Methionine | |||||||
Detailed Information |
Meta Info
![]() |
[44], [15] | |||||
Description |
Methionine supplementation could increase levels of H3K4me3 in brain.
|
||||||
Metabolite Name: Valerate | |||||||
Detailed Information |
Meta Info
![]() |
[44], [15] | |||||
Description |
Valerate has been shown to result in the increase in histone H3 acetylation
|
||||||
Metabolite Name: Spermidine | |||||||
Detailed Information |
Meta Info
![]() |
[47], [11] | |||||
Description |
Spermidine could decrease the expression levels of Ac-Histone H3.
|
||||||
Metabolite Name: S-Adenosyl Homocysteine (SAH) | |||||||
Detailed Information |
Meta Info
![]() |
[48], [49] | |||||
Description |
S-Adenosylhomocysteine (SAH) could induce changes in H3K4me3.
|
||||||
Metabolite Name: Iso-Valerate | |||||||
Detailed Information |
Meta Info
![]() |
[50] | |||||
Description |
Isovalerate has been shown to increased bulk histone H3 acylation.
|
||||||
Metabolite Name: beta-glucan | |||||||
Detailed Information |
Meta Info
![]() |
[51] | |||||
Description |
beta-glucan has been shown to increase the H3K27Ac modification in the promoter region of EIF4eBP in human monocytes.
|
||||||
Metabolite Name: beta-glucan | |||||||
Detailed Information |
Meta Info
![]() |
[51] | |||||
Description |
beta-glucan has been shown to increase the H3K4me3 modification in the promoter region of EIF4eBP in human monocytes.
|
||||||
Metabolite Name: beta-glucan | |||||||
Detailed Information |
Meta Info
![]() |
[51] | |||||
Description |
beta-glucan has been shown to increase the H3K27Ac modification in the promoter region of hexokinase (HK1) in human monocytes.
|
||||||
Metabolite Name: beta-glucan | |||||||
Detailed Information |
Meta Info
![]() |
[51] | |||||
Description |
beta-glucan has been shown to increase the H3K4me3 modification in the promoter region of hexokinase (HK1) in human monocytes.
|
||||||
Metabolite Name: beta-glucan | |||||||
Detailed Information |
Meta Info
![]() |
[51] | |||||
Description |
beta-glucan has been shown to increase the H3K27Ac modification in the promoter region of pyruvate kinase (PKM) in human monocytes.
|
||||||
Metabolite Name: beta-glucan | |||||||
Detailed Information |
Meta Info
![]() |
[51] | |||||
Description |
beta-glucan has been shown to increase the H3K4me3 modification in the promoter region of pyruvate kinase (PKM) in human monocytes.
|
Protein(s) with this epigenetic modification | |||||||
---|---|---|---|---|---|---|---|
Protein Name: Pyruvate oxidase SpxB | |||||||
Detailed Information |
Pro Info
![]() |
[4] | |||||
Description |
Pyruvate oxidase SpxB could be induce specific histone modifications
|
||||||
Protein Name: HP0175 | |||||||
Detailed Information |
Pro Info
![]() |
[52] | |||||
Description |
HP0175 responsible for IL-6 expression could be correlated with phosphorylation of H3S10 at the IL-6 promoter.
|
||||||
Protein Name: CagA | |||||||
Detailed Information |
Pro Info
![]() |
[53] | |||||
Description |
Helicobacter pylori's pathogenicity island cagA could induce H3 Ser10 dephosphorylation in AGS cells.
|
||||||
Protein Name: cagPAI | |||||||
Detailed Information |
Pro Info
![]() |
[53] | |||||
Description |
Helicobacter pylori-induces histone H3 Ser10 dephosphorylation and cagPAI is responsible for this effect.
|
||||||
Protein Name: vacA | |||||||
Detailed Information |
Pro Info
![]() |
[53] | |||||
Description |
Helicobacter pylori's pathogenicity island vacA could induce H3 Ser10 dephosphorylation in AGS cells.
|
||||||
Protein Name: Rv1988 | |||||||
Detailed Information |
Pro Info
![]() |
[54] | |||||
Description |
Rv1988 (Arginine methyltransferase) has been shown to dimethylate an arginine residue located to the core region of histone H3.
|
||||||
Protein Name: RomA | |||||||
Detailed Information |
Pro Info
![]() |
[55] | |||||
Description |
The Legionella pneumophila effector RomA trimethylates H3K14 has a main impact on the CXCL1 promoter region.
|
||||||
Protein Name: RomA | |||||||
Detailed Information |
Pro Info
![]() |
[55] | |||||
Description |
The type IV secreted effector RomA of Legionella pneumophila decreases H3K14 acetylation to repress host gene expression.
|
||||||
Protein Name: RomA | |||||||
Detailed Information |
Pro Info
![]() |
[55] | |||||
Description |
The Legionella pneumophila effector RomA trimethylates H3K14 has a main impact on the CXCL2 promoter region.
|
||||||
Protein Name: LegAS4 | |||||||
Detailed Information |
Pro Info
![]() |
[56] | |||||
Description |
LegAS4 has been shown to tri-methylate histone H3 on lysine 14.
|
||||||
Protein Name: Rv3423.1 | |||||||
Detailed Information |
Pro Info
![]() |
[57] | |||||
Description |
Rv3423.1 has been shown to generate euchromatic histone marks by acetylating histone H3 at lysine 9.
|
||||||
Protein Name: Rv3423.1 | |||||||
Detailed Information |
Pro Info
![]() |
[57] | |||||
Description |
Rv3423.1 has been shown to generate euchromatic histone marks by acetylating histone H3 at lysine 14.
|
||||||
Protein Name: Ankyrin A | |||||||
Detailed Information |
Pro Info
![]() |
[58] | |||||
Description |
Ankyrin A (AnkA) could be decrease the level of histone H3 acetylation at the CYBB locus, particularly around AnkA binding sites.
|
||||||
Protein Name: cagPAI | |||||||
Detailed Information |
Pro Info
![]() |
[59] | |||||
Description |
Helicobacter pylori decreases acetylation of Lys23 of histone H3 dependent on genes present on its pathogenicity island cagPAI.
|
||||||
Protein Name: CpnSET | |||||||
Detailed Information |
Pro Info
![]() |
[59] | |||||
Description |
CpnSET has been shown to methylate mouse histone H3 in vitro.
|
||||||
Protein Name: RomA | |||||||
Detailed Information |
Pro Info
![]() |
[59] | |||||
Description |
RomA has been shown to specifically methylate lysine 14 of the histone H3 (H3K14).
|
||||||
Protein Name: BbSET | |||||||
Detailed Information |
Pro Info
![]() |
[59], [60] | |||||
Description |
BbSET could be have methyltransferase activity like LegAS4, and Lys4 of histone H3 (H3K4) as its target.
|
||||||
Protein Name: LegAS4 | |||||||
Detailed Information |
Pro Info
![]() |
[59], [60] | |||||
Description |
LegAS4 has methyltransferase activity like RomA, while Lys4 of histone H3 (H3K4) as its target.
|
||||||
Protein Name: BtSET | |||||||
Detailed Information |
Pro Info
![]() |
[60] | |||||
Description |
BtSET (Histone lysine methyltransferase) has been shown to promote H3K4 methylation of rDNA chromatin
|
||||||
Protein Name: LntA | |||||||
Detailed Information |
Pro Info
![]() |
[61] | |||||
Description |
LntA can inhibit the binding of the chromatin suppressor BAHD1 of epithelial cells to histone H3 on the promoter of interferon (IFN) stimulated genes
|
||||||
Protein Name: NuE | |||||||
Detailed Information |
Pro Info
![]() |
[62] | |||||
Description |
NuE could methylates H3.
|
||||||
Protein Name: OspF | |||||||
Detailed Information |
Pro Info
![]() |
[63] | |||||
Description |
OspF has been shown to strongly repressed accumulation of histone H3 phosphorylated at Ser10 at the IL8 promoter.
|
||||||
Protein Name: CagA | |||||||
Detailed Information |
Pro Info
![]() |
[64] | |||||
Description |
The cytotoxin-associated gene A (CagA) of Helicobacter pylori enhances EZH2 expression, leading to increased H3K27 trimethylation.
|
||||||
Protein Name: InIB | |||||||
Detailed Information |
Pro Info
![]() |
[65] | |||||
Description |
InlB can deacetylates histone H3 on lysine 18 (H3K18) and the ctivity of SIRT2 on H3K18 is important for infection in vivo.
|
||||||
Protein Name: InlB | |||||||
Detailed Information |
Pro Info
![]() |
[65] | |||||
Description |
The bacterial factor InlB of the bacterium Listeria monocytogenes could influence the process of deacetylates histone H3 on lysine 18 (H3K18).
|
||||||
Protein Name: InlB | |||||||
Detailed Information |
Pro Info
![]() |
[65] | |||||
Description |
The bacterial factor InlB of the bacterium Listeria innocua could influence the process of deacetylates histone H3 on lysine 18 (H3K18).
|
||||||
Protein Name: Alpha-hemolysin | |||||||
Detailed Information |
Pro Info
![]() |
[66] | |||||
Description |
hlyA could significantly decrease the acetyl-CoA level, leading to reduced H3K9 histone acetylation in the promotor region of CXCL8.
|
||||||
Protein Name: Lethal toxin | |||||||
Detailed Information |
Pro Info
![]() |
[67] | |||||
Description |
Lethal toxin has been shown to impair histone H3K14 acetylation and IL-8 and KC promoter accessibility.
|
||||||
Protein Name: Lethal toxin | |||||||
Detailed Information |
Pro Info
![]() |
[67] | |||||
Description |
Lethal toxin has been shown to impair histone H3S10 phosphorylation and IL-8 and KC promoter accessibility.
|
||||||
Protein Name: Listeriolysin O | |||||||
Detailed Information |
Pro Info
![]() |
[68] | |||||
Description |
Listeriolysin O(LLO) has been shown to induce a drastic dephosphorylation of Serine 10 on histone H3.
|
||||||
Protein Name: Listeriolysin O | |||||||
Detailed Information |
Pro Info
![]() |
[68] | |||||
Description |
Listeriolysin O(LLO) has been shown to decrease the level of associated phospho-Ser10 H3 of cxcl2 gene.
|
||||||
Protein Name: Listeriolysin O | |||||||
Detailed Information |
Pro Info
![]() |
[68] | |||||
Description |
Listeriolysin O(LLO) has been shown to decrease the level of associated phospho-Ser10 H3 of Dusp4 gene.
|
||||||
Protein Name: Listeriolysin O | |||||||
Detailed Information |
Pro Info
![]() |
[68] | |||||
Description |
Listeriolysin O(LLO) has been shown to increase the level of associated phospho-Ser10 H3 of Prkdc gene.
|
||||||
Protein Name: Perfringolysin O | |||||||
Detailed Information |
Pro Info
![]() |
[68] | |||||
Description |
Perfringolysin (PFO) has been shown to induce a drastic dephosphorylation of Serine 10 on histone H3.
|
||||||
Protein Name: Pneumolysin | |||||||
Detailed Information |
Pro Info
![]() |
[68] | |||||
Description |
Pneumolysin (PLY) has been shown to induce a drastic dephosphorylation of Serine 10 on histone H3.
|
||||||
Protein Name: Aerolysin | |||||||
Detailed Information |
Pro Info
![]() |
[69] | |||||
Description |
Aerolysin has been shown to dephosphorylates histone H3.
|
||||||
Protein Name: Listeriolysin O | |||||||
Detailed Information |
Pro Info
![]() |
[69] | |||||
Description |
Listeriolysin O(LLO) has been shown to dephosphorylates histone H3.
|
||||||
Protein Name: Adhesion and penetration protein | |||||||
Detailed Information |
Pro Info
![]() |
[70] | |||||
Description |
Meningococcal serine protease A (MspA) has been shown to proteolytically cleave histone H3 in vitro.
|
||||||
Protein Name: Meningococcal serine protease A | |||||||
Detailed Information |
Pro Info
![]() |
[70] | |||||
Description |
Meningococcal serine protease A (MspA) has been shown to proteolytically cleave histone H3 in vitro.
|
||||||
Protein Name: Rv2966c | |||||||
Detailed Information |
Pro Info
![]() |
[71] | |||||
Description |
Rv2966c could bind to specific DNA sequences and interacted with the activating chromatin marks H3K4me3.
|
||||||
Protein Name: Rv3763 | |||||||
Detailed Information |
Pro Info
![]() |
[72] | |||||
Description |
Rv3763 could inhibite the increased acetylation of histones H3 at CIITA pIV locus.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.